In addition, several reports have established a solid connection between excessive IL-23 production and the development of inflammatory diseases in murine models of experimental autoimmune encephalomyelitis (EAE), psoriasis, and inflammatory bowel disease [1–3]. Here, IL37 is linked to inflammatory bowel disease.